Skip to main content
Fig. 7 | Cardiovascular Diabetology

Fig. 7

From: Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway

Fig. 7

Effects of Zn(ASA)2 on myocardial protein expression. Immunoblot analysis for a CD36, b insulin receptor (IR)-β, c glucose transporter (GLUT)-4, d phosphorylated PI3K, e PI3K, f phosphorylated phosphatidylinositol 3-kinase-(PI3K)/PI3K ratio, g phosphorylated, h total AKT and i phosphorylated AKT/total Akt ratio protein band densities in the myocardium. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), housekeeping protein was used as reference. Values are mean ± SEM, n = 6–7. *P < 0.05 vs ZL, #P < 0.05 vs ZDF, $P < 0.05 vs Zn(ASA)2. Zn(ASA) 2 indicates a zinc complex of acetylsalicylic acid, ZDF Zucker diabetic fatty rats, ZL Zucker lean

Back to article page